GlassScriptPhysician profile
Perry J Cole
NPI 1053417428
$7,566.08
in general payments reported to CMS, 2019-2025
49 companies · $1,533 in 2025
The $1,533 reported for 2025 was more than what 77% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $295 · 2021: $2,074 · 2022: $1,325 · 2023: $933 · 2024: $1,276 · 2025: $1,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,742.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,374.02 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,198.29 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $957.88 | 2020-2025 | Xtampza, Belbuca |
| Abbvie INC. | $760.13 | 2021-2025 | Ubrelvy, Qulipta |
| Pfizer INC. | $423.77 | 2021-2025 | |
| Amgen INC. | $347.88 | 2020-2022 | |
| Averitas Pharma INC. | $294.42 | 2023-2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $224.54 | 2022 | |
| Protega Pharmaceutials INC | $191.40 | 2023-2025 | Roxybond |
| Medtronic, INC. | $162.30 | 2022-2024 | Vanta Adaptivestim |
| Lundbeck LLC | $133.43 | 2022-2025 | Vyepti |
| Grt US Holding, INC. | $125.21 | 2021-2022 | |
| Lilly USA, LLC | $118.58 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $99.21 | 2023-2025 | Quviviq, Quviviq |
| Merck Sharp & Dohme LLC | $90.06 | 2022-2023 | Belsomra |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $85.76 | 2023-2025 | Movantik |
| Almatica Pharma LLC | $73.71 | 2021-2023 | Gralise |
| Globus Medical, INC. | $73.47 | 2025 | Senza |
| Abbott Laboratories | $70.10 | 2022-2024 | Eterna |
| Masimo Corporation | $55.16 | 2023-2024 | Patient Safetynet System, Bridge |
| Tersera Therapeutics LLC | $54.85 | 2025 | Prialt |
| Si-Bone, INC. | $50.81 | 2025 | |
| Alnylam Pharmaceuticals INC. | $49.01 | 2021 | |
| Biodelivery Sciences International, INC. | $46.82 | 2021 | |
| Spr Therapeutics, INC | $43.56 | 2024 | Sprint Pns System |
| Avanos Medical | $38.16 | 2024 | Standard Rf Disposables |
| Redhill Biopharma INC. | $37.29 | 2021 | |
| Saluda Medical Americas, INC. | $25.00 | 2025 | Evoke |
| Assertio Therapeutics, INC. | $24.84 | 2019 | |
| Tonix Medicines, INC. | $22.69 | 2025 | Tonmya |
| Boston Scientific Corporation | $22.32 | 2024 | Intracept |
| Orexo US, INC. | $22.01 | 2023 | Zubsolv |
| Hikma Pharmaceuticals USA | $21.52 | 2022 | |
| Daiichi Sankyo INC. | $19.12 | 2019 | |
| Medtronic USA, INC. | $19.01 | 2020 | |
| Bioventus LLC | $18.12 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.97 | 2024 | Exparel, Iovera, Zilretta |
| Nevro Corp. | $16.53 | 2024 | Senza |
| Novartis Pharmaceuticals Corporation | $16.45 | 2020 | |
| Kaleo, INC. | $16.36 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.59 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.29 | 2023 | Lyvispah |
| Curonix LLC | $15.02 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Trevena, INC. | $14.33 | 2022 | |
| Allergan, INC. | $14.21 | 2022 | |
| Painteq LLC | $14.18 | 2024 | Painteq |
| Horizon Therapeutics Plc | $12.74 | 2020 | |
| Virtus Pharmaceuticals LLC | $12.20 | 2021 | |
| Zyla Life Sciences, INC. | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.